Evidence-Based Nutrition Practice Guidelines of Toolkit and Preliminary Outcomes

Academy of Nutrition and Dietetics54 enrolled

Overview

The goal of this study is to field test ADA's Type 2 Diabetes Evidence-Based nutrition Practice Guidelines (EBNPG) for Adults in 2008 as a tool for registered dietitians (RDs) for their patients with with type 2 diabetes who have no evidence of organ damage. A six month pilot study will be conducted to determine the feasibility of training RDs in documenting the outcomes of implementing Medical Nutrition Therapy (MNT) using ADA's evidence-based GL for T2D.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Type 2 Diabetes Mellitus

Eligibility

Sex: ALLMin age: 19 YearsMax age: 79 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * over 19 years * no documented claims for the treatment of TD over the past 7 years * no MNT claims submitted within the past 12 months * not under RD care * able to make visits to the clinic per guidelines Exclusion Criteria: * not in end-stage renal disease or renal insufficiency; history of Cardiovascular Disease,Chronic Athrosclerotic Disease, or Myocardial Infection; Chronic Obstructive Pulmonary Disease, untreated depression, severe psychiatric illness; cancer diagnosis in previous two years or on-going radiation or chemotherapy treatment; Congestive Heart Failure. * pregnant or lactating at time of study * presence of cognitive limitations that preclude making lifestyle or dietary changes as assessed by the RD during the initial interview

Outcomes

Primary Outcomes

Implementation of new evidence-based nutrition practice guidelines

RDs and RDs with CDE credential, will have reached the target professional goals in successful implementation of new evidence-based nutrition practice guidelines in daily clinical practice.

Time frame: six months

Secondary Outcomes

Improved health outcomes

Patients counseled by either an RD, or an RD with CDE credential, will exhibit improvements in critical health outcomes, relative to baseline levels.

Time frame: six months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.